...

首页> 外文期刊>European Journal of Cancer Supplements >6616 POSTER Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

【24h】

6616 POSTER Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

机译：6616 POSTER II期研究，每周进行以紫杉醇和吉西他滨为二线治疗的铂类化疗后晚期非小细胞肺癌的二线治疗

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2007年第4期| 共1页
作者
K.Mori; Y.Kamiyama; T.Kondo; T.Kodama;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy [J] . Kiyoshi Mori, Yukari Kamiyama, Tetsuro Kondo, Cancer Chemotherapy and Pharmacology . 2007 ,第2期

机译：每周一次以紫杉醇和吉西他滨为二线治疗的晚期铂类化学疗法治疗晚期非小细胞肺癌的II期研究
2. A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens [J] . Christos Kosmas, Nicolas Tsavaris, Konstantinos Syrigos, Cancer Chemotherapy and Pharmacology . 2007 ,第1期

机译：在先前紫杉烷+铂类方案治疗后的非小细胞肺癌中，吉西他滨和伊立替康每两周进行二线化疗的I-II期研究
3. 1122 ORAL Paclitaxel poliglumex vs. gemcitabine or vinorelbine for the treatment of performance status (PS) 2 patients with chemotherapy-na?ve advanced non-small cell lung cancer (NSCLC): the STELLAR 4 phase III study [J] . European Journal of Cancer Supplements . 2005 ,第2期

机译：1122年STALLAR 4期III期研究1122 ORAL紫杉醇poliglumex与吉西他滨或长春瑞滨治疗性能状态（PS）的2例未经化疗的晚期非小细胞肺癌（NSCLC）患者
4. Weekly Paclitaxel Therapy as the Second-line Chemotherapy to TS-1 for Advanced/Metastatic Gastric Cancer [C] . M. Fujishima, H. Imamura, H. Furukawa, International Gastric Cancer Congress . 2005

机译：每周紫杉醇治疗作为先进/转移性胃癌的二线化学疗法至TS-1
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer [O] . Wei-Ze Lv, Zhong Lin, Si-Yang Wang, 2019

机译：脂质体紫杉醇和奈达铂联合双周化疗方案治疗晚期鳞状细胞癌的第二阶段研究
7. A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study). [O] . Vergnenègre Alain, Tillon Julie, Corre Romain, 2009

机译：一项II期随机临床试验，评估了在接受两个疗程的顺铂-吉西他滨，紫杉醇-吉西他滨对化疗双重治疗的早期改良与继续进行顺铂-吉西他滨化疗之后的稳定疾病的晚期非小细胞肺癌患者（GFPC 03-01研究）。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号